ALDX Earnings Aldeyra Therapeutics, Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Net income
ROE
Reported EPS history
1–34 of 34
| Q2 2026 | 2026-06-30 | -0.15 | 2026-08-06 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.06 | 2026-05-07 | 10-Q |
| FY 2025 | 2025-12-31 | -0.56 | 2026-02-27 | 10-K |
| Q3 2025 | 2025-09-30 | -0.46 | 2025-11-05 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.33 | 2026-08-06 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.17 | 2026-05-07 | 10-Q |
| FY 2025 | 2024-12-31 | -0.94 | 2026-02-27 | 10-K |
| Q3 2025 | 2024-09-30 | -0.67 | 2025-11-05 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.42 | 2025-08-07 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.14 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -0.64 | 2025-02-28 | 10-K |
| Q3 2024 | 2023-09-30 | -0.56 | 2024-11-07 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.42 | 2024-08-01 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.27 | 2024-05-02 | 10-Q |
| FY 2023 | 2022-12-31 | -1.06 | 2024-03-07 | 10-K |
| Q3 2023 | 2022-09-30 | -0.84 | 2023-11-03 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.59 | 2023-08-03 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.29 | 2023-05-04 | 10-Q |
| FY 2022 | 2021-12-31 | -1.07 | 2023-03-09 | 10-K |
| Q3 2022 | 2021-09-30 | -0.80 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.52 | 2022-08-05 | 10-Q |
| Q1 2016 | 2016-03-31 | -0.51 | 2016-05-09 | 10-Q |
| FY 2015 | 2015-12-31 | -1.40 | 2016-03-30 | 10-K |
| Q3 2015 | 2015-09-30 | -0.94 | 2015-11-13 | 10-Q |
| Q2 2015 | 2015-06-30 | -0.58 | 2015-08-14 | 10-Q |
| Q1 2016 | 2015-03-31 | -0.32 | 2016-05-09 | 10-Q |
| FY 2015 | 2014-12-31 | -3.09 | 2016-03-30 | 10-K |
| Q3 2015 | 2014-09-30 | -2.89 | 2015-11-13 | 10-Q |
| Q2 2015 | 2014-06-30 | -3.53 | 2015-08-14 | 10-Q |
| Q1 2015 | 2014-03-31 | -4.04 | 2015-05-14 | 10-Q |
| FY 2014 | 2013-12-31 | -17.61 | 2015-03-23 | 10-K |
| Q3 2014 | 2013-09-30 | -5.37 | 2014-11-12 | 10-Q |
| Q2 2014 | 2013-06-30 | -18.50 | 2014-08-07 | 10-Q |
| Q1 2014 | 2013-03-31 | -13.03 | 2014-06-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.